Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Graphene Specialists Haydale Granted Key Patent

Abstract:
Haydale announces that it has received confirmation from the European Patent Office (EPO) of the decision to grant a European Patent for its proprietary HDPlas® functionalisation process for graphene and other nanoparticulate materials.

Graphene Specialists Haydale Granted Key Patent

Ammanford, UK | Posted on October 20th, 2015

The European Patent is the key process patent underlying the Company's proprietary functionalisation treatment and is one of a number arising from the families of patent applications surrounding Haydale's unique plasma functionalisation process. Haydale already has a granted patent in China and has visibility on the patent application in Australia, which is expected to proceed to grant within the next 3-4 months.

Crucially, the European Patent is not limited to graphene or carbon materials but also covers all nanoparticles. Whilst Haydale's immediate focus remains on commercialising graphene and other nanocarbons, this important award means that the Haydale process can now be extended in Europe to a wide range of alternative materials thereby considerably extending the future opportunities and applications using its HDPlas® functionalisation process. Furthermore, the receipt of the European Patent will allow Haydale to grant licenses of its plasma process to graphene producers or applications houses throughout Europe. This patent grant ensures that Haydale can implement its development strategy knowing that the Company's key intellectual property is protected.

Ray Gibbs, Haydale Chief Executive commented "We believe that this new European patent provides us with significant credibility amongst existing and potential customers across our target markets. Independent published research here in the UK and in the USA demonstrates the benefits of our HDPlas® process and we now have customers placing repeat orders. In addition we have a number of industrial partnerships in place to develop the next generation of advanced materials that will benefit from the use of our functionalised graphene". He concluded "Now that we have our HDPlas® functionalisation process protected by patent this gives us great belief and confidence that Haydale is in a unique position to benefit from the adoption of graphene enhanced materials by a range of industries."

####

About Haydale Ltd.
Haydale Ltd, based in South Wales, UK and housed in a purpose-built facility for processing and handling nanomaterials, is facilitating the application of graphene's and other nanomaterials in fields such as aerospace, inks, sensors, energy storage, photovoltaics, composites, paints and coatings. Haydale has developed a patent-pending proprietary scalable plasma process to functionalise graphene and other nanomaterials. This enabling technology can provide Haydale with a rapid and highly cost-efficient method of supplying tailored solutions to enhance applications for both raw material suppliers and product manufacturers.

For more information, please click here

Contacts:
Worldwide HQ
Haydale Ltd.
Clos Fferws, Parc Hendre,
Capel Hendre,
Ammanford,
Carmarthenshire, SA18 3BL
UK
Tel: +44-1269-842946
Email:

Copyright © Haydale Ltd.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Graphene/ Graphite

Breakthrough in proton barrier films using pore-free graphene oxide: Kumamoto University researchers achieve new milestone in advanced coating technologies September 13th, 2024

A 2D device for quantum cooling:EPFL engineers have created a device that can efficiently convert heat into electrical voltage at temperatures lower than that of outer space. The innovation could help overcome a significant obstacle to the advancement of quantum computing technol July 5th, 2024

First human trial shows ‘wonder’ material can be developed safely: A revolutionary nanomaterial with huge potential to tackle multiple global challenges could be developed further without acute risk to human health, research suggests February 16th, 2024

NRL discovers two-dimensional waveguides February 16th, 2024

Materials/Metamaterials/Magnetoresistance

New material to make next generation of electronics faster and more efficient With the increase of new technology and artificial intelligence, the demand for efficient and powerful semiconductors continues to grow November 8th, 2024

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project